74 results
Page 2 of 4
6-K
EX-99.2
vmlf0npnb496t5e5s3
11 Aug 22
Current Report
4:05pm
6-K
EX-99.4
afi578u
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.2
vlx5m4 y4fc9jn77zg
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.3
ja5jo8v ux9xh9hwj
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.2
1d83t2d1wkp w71
6 Jan 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
udtmvwdnybvdc8gkde
20 Dec 21
SciSparc Announces Approval of Uplisting to The Nasdaq Capital Market
4:45pm
POS AM
ju6ymcdrx3ahb1
8 Oct 21
Prospectus update (post-effective amendment)
12:00am
POS AM
pywmyykk
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
POS AM
r5po9manyvg1ite1l06s
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
F-1/A
dk47yfg40gxk
28 Apr 21
Registration statement (foreign) (amended)
4:38pm
F-1
fpw fz85zuqju
21 Apr 21
Registration statement (foreign)
4:17pm
POS AM
qcnwswp33gna4k4yljp8
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
POS AM
3kg9zwzp
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99.2
zmu0643gok4d
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.1
zhi4uk3 5f
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am
424B4
3o08zndxhz wwua
20 Nov 20
Prospectus supplement with pricing info
4:43pm